Compare Lumen Technologies Inc (LUMN) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lumen Technologies Inc vs Tilray Brands Inc — how do they compare? Lumen Technologies Inc trades at $6.3 (market cap $6.47B), while Tilray Brands Inc trades at $4.23 (market cap $530.86M). The key difference: Lumen Technologies Inc is far larger — about 12.2× Tilray Brands Inc's market cap, and Lumen Technologies Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| LUMN | TLRY | |
|---|---|---|
Market Cap | $6.47B | $530.86M |
Sector | Media | Health |
52-Week High | $11.83 | $21.00 |
52-Week Low | $3.70 | $4.30 |
Enterprise Value | $18.10B | $628.01M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LUMN trades at $6.275, down 0.08% on the day, with a bearish technical signal but oversold RSI readings. The company reported a net loss of $1.74B in 2025 despite beating EPS estimates in two of the last three quarters. Recent news highlights strategic acquisitions like Alkira to bolster its AI networking capabilities, while the balance sheet shows high debt levels of $17.49B long-term.
The outlook remains challenging due to persistent losses and heavy debt, though cost-cutting initiatives and a $13B contract backlog offer potential upside. Analyst consensus is cautious with a $8.25 price target, but the stock's deep value (P/S 0.52) may attract contrarians if EBITDA improves. Key risks include execution on turnaround plans and interest expense pressure.
TLRY trades at $4.24, down 1.4% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821 million, reflecting severe profitability challenges. Analyst consensus is mixed, with 25% buy ratings but 65% hold. Recent developments include medical cannabis expansion in Panama and the HelloMD acquisition, aiming to strengthen its global footprint.
The outlook remains highly uncertain due to persistent losses and high debt-to-asset ratio of 12.25%. While acquisitions and international expansion offer growth potential, profitability risks and regulatory hurdles pose significant challenges for investors seeking a turnaround in the volatile cannabis sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lumen Technologies Inc
With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
